207 related articles for article (PubMed ID: 330286)
21. Gastro-intestinal tolerance of anti-inflammatory drugs.
Bianchi Porro G; Petrillo M; Benassai D; Caruso E; Fumagalli M; Montrone F
Acta Rhumatol Belg; 1977; 1(3-4):189-212. PubMed ID: 756666
[No Abstract] [Full Text] [Related]
22. Prevention of aspirin-induced faecal blood loss by prostaglandin E2.
Cohen MM; Cheung G; Lyster DM
Gut; 1980 Jul; 21(7):602-6. PubMed ID: 7000631
[TBL] [Abstract][Full Text] [Related]
23. Comparative studies on the gastrointestinal lesions caused by several nonsteroidal anti-inflammatory agents in rats.
Suwa T; Urano H; Kohno Y; Suzuki A; Amano T
Agents Actions; 1987 Jun; 21(1-2):167-72. PubMed ID: 3498312
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.
Cohen A; Boeijinga JK; van Haard PM; Schoemaker RC; van Vliet-Verbeek A
Br J Clin Pharmacol; 1992 Jan; 33(1):33-8. PubMed ID: 1540488
[TBL] [Abstract][Full Text] [Related]
25. [Combination therapy with acetylsalicylic acid and non-aspirin nonsteroidal anti-inflammatory drugs].
Reuther LØ; Andersen SE
Ugeskr Laeger; 2006 Mar; 168(13):1310-4. PubMed ID: 16579883
[TBL] [Abstract][Full Text] [Related]
26. Acetylsalicylic acid and gastrointestinal bleeding measurement of blood loss using a modified radioactive chromium method.
Arvidsson B; Magnusson B; Sölvell ; Magnusson A
Scand J Gastroenterol; 1975; 10(2):155-60. PubMed ID: 1091965
[TBL] [Abstract][Full Text] [Related]
27. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
[TBL] [Abstract][Full Text] [Related]
28. [Double-blind comparative study of indoprofen and ibuprofen in patients with osteoarthrosis].
Giro C; Lo Presti R
G Clin Med; 1979 Jan; 60(1):65-71. PubMed ID: 378745
[No Abstract] [Full Text] [Related]
29. [Risk factors for gastrointestinal bleeding associated with low-dose aspirin].
Sibilia J; Ravaud P; Marck G
Presse Med; 2003 Nov; 32(37 Pt 2):S9-16. PubMed ID: 14763349
[TBL] [Abstract][Full Text] [Related]
30. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
32. Basic pain relievers. It's wise to use caution.
Mayo Clin Health Lett; 2012 Sep; 30(9):6. PubMed ID: 23097814
[No Abstract] [Full Text] [Related]
33. Controlled comparison of gastric lesions and gastrointestinal blood loss with fluproquazone and acetylsalicylic acid (ASA) in healthy subjects.
Gillberg RE; Korsan-Bengtsen K; Magnusson B; Nyberg G; Schütz W
Arzneimittelforschung; 1981; 31(5a):936-7. PubMed ID: 6973991
[No Abstract] [Full Text] [Related]
34. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
Farkouh ME; Kirshner H; Harrington RA; Ruland S; Verheugt FW; Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Gimona A; Matchaba P; Hawkey CJ; Chesebro JH;
Lancet; 2004 Aug 21-27; 364(9435):675-84. PubMed ID: 15325832
[TBL] [Abstract][Full Text] [Related]
35. Gastro-intestinal blood loss with high dose tilcotil (Ro 12-0068) and aspirin: an open crossover clinical trial and pharmacokinetic assessment in normal volunteers.
Bird HA; Pickup ME; Taylor P; Lowe JR; McEvoy M; Galloway DB; Wright V
Curr Med Res Opin; 1983; 8(6):412-6. PubMed ID: 6342955
[TBL] [Abstract][Full Text] [Related]
36. Forty years of ibuprofen use.
Moore N
Int J Clin Pract Suppl; 2003 Apr; (135):28-31. PubMed ID: 12723744
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males.
Salom IL; Jacob G; Jallad N; Perdomo CA; Mullane JF; Weidler D
J Clin Pharmacol; 1984; 24(5-6):240-6. PubMed ID: 6235249
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulations.
Zuin M; Podda M; Selmi C; Giorgini A; Zermiani P; Mandelli G; Sacchetta AC; Candiani C
Arzneimittelforschung; 2000 Sep; 50(9):837-42. PubMed ID: 11050702
[TBL] [Abstract][Full Text] [Related]
39. Preclinical studies on indoprofen, a new non-steroidal analgesic-antiinflammatory agent.
Buttinoni A; Tommasini R
Eur J Rheumatol Inflamm; 1981; 4(1):3-10. PubMed ID: 6804240
[TBL] [Abstract][Full Text] [Related]
40. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.
Henry D; Lim LL; Garcia Rodriguez LA; Perez Gutthann S; Carson JL; Griffin M; Savage R; Logan R; Moride Y; Hawkey C; Hill S; Fries JT
BMJ; 1996 Jun; 312(7046):1563-6. PubMed ID: 8664664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
